BIR/IDUG Molecular Radiotherapy Dosimetry

29th September - 2nd October 2020   (GMT+01:00) Europe/London

This event is going virtual! 
Tuesday 29 September - Friday 2 October each day from 12:00-13:00 BST
4 CPD


You will need to sign-up with the BIR before registering. Please sign-up or login here.

Once logged in, click on the education tab and select education and events, you will then be able to register onto the event. 


Following three highly successful BIR/IDUG conferences in 2014, 2016 and 2018, this is an excellent opportunity to hear about the future of molecular radiotherapy dosimetry. Because of the ongoing uncertainty, this event will now be held virtually over four consecutive days during hour-long sessions from 12:00-13:00 BST. If you are unable to attend any of the live sessions, you will be able to access them on demand after the live sessions if you have registered for this event and still be able to get CPD for your participation. 

 

View the virtual event programme 

 

Registration fees:

EARLY BIRD Registration fees*:

BIR and IDUG members FREE
Non members £60
*Early bird rates expire 4 September 2020

Registration fees*:
BIR members FREE
Non members £80

*VAT added at checkout

Registration instructions
In order to register for this event you must first create a MyBIR portal. This is a free account with the BIR which will allow you to register for events and to retrieve receipts and CPD certificates. Once this is created, you can then register onto the event. If you have registered for a BIR event in the past you can login to your account first and then click on the register now button. You do not need to be a member of BIR or a radiologist to register for this event. All healthcare professionals are welcome. If you are having any issues registering please email conference@bir.org.uk

Venue

Speakers

Sponsors

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Hermes Medical Solutions

MIM Software Inc.

MIM Software offers a suite of applications that support Radiology and Nuclear Medicine’s important role in the patient care pathway. MIM products emphasize the importance of quantitation, collaboration, and data management. MIM SurePlan™ MRT provides voxel-based dosimetry for Molecular Radiotherapy, deformable registration, and timesaving tools for organ and tumor segmentation.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit https://www.siemens-healthineers.com/en-uk/